These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9754442)

  • 1. Quantitative analysis of T2 signal intensities in Alzheimer's disease.
    Parsey RV; Krishnan KR
    Psychiatry Res; 1998 Jun; 82(3):181-5. PubMed ID: 9754442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new MRI ratio method for in-vivo estimation of signal hypointensity in aging and Alzheimer's disease.
    Parsey RV; Krishnan KR
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Nov; 21(8):1257-67. PubMed ID: 9460090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative MRI and laser ablation-inductively coupled plasma-mass spectrometry imaging of iron in the frontal cortex of healthy controls and Alzheimer's disease patients.
    Bulk M; Abdelmoula WM; Geut H; Wiarda W; Ronen I; Dijkstra J; van der Weerd L
    Neuroimage; 2020 Jul; 215():116808. PubMed ID: 32289451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex.
    Hare DJ; Raven EP; Roberts BR; Bogeski M; Portbury SD; McLean CA; Masters CL; Connor JR; Bush AI; Crouch PJ; Doble PA
    Neuroimage; 2016 Aug; 137():124-131. PubMed ID: 27233149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical Iron Reflects Severity of Alzheimer's Disease.
    van Duijn S; Bulk M; van Duinen SG; Nabuurs RJA; van Buchem MA; van der Weerd L; Natté R
    J Alzheimers Dis; 2017; 60(4):1533-1545. PubMed ID: 29081415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.
    Bartzokis G; Sultzer D; Mintz J; Holt LE; Marx P; Phelan CK; Marder SR
    Biol Psychiatry; 1994 Apr; 35(7):480-7. PubMed ID: 8018799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain.
    Haacke EM; Ayaz M; Khan A; Manova ES; Krishnamurthy B; Gollapalli L; Ciulla C; Kim I; Petersen F; Kirsch W
    J Magn Reson Imaging; 2007 Aug; 26(2):256-64. PubMed ID: 17654738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI of the normal brain from early childhood to middle age. II. Age dependence of signal intensity changes on T2-weighted images.
    Autti T; Raininko R; Vanhanen SL; Kallio M; Santavuori P
    Neuroradiology; 1994 Nov; 36(8):649-51. PubMed ID: 7862288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    Moon Y; Han SH; Moon WJ
    J Alzheimers Dis; 2016; 51(3):737-45. PubMed ID: 26890777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-field magnetic resonance imaging of brain iron in Alzheimer disease.
    Schenck JF; Zimmerman EA; Li Z; Adak S; Saha A; Tandon R; Fish KM; Belden C; Gillen RW; Barba A; Henderson DL; Neil W; O'Keefe T
    Top Magn Reson Imaging; 2006 Feb; 17(1):41-50. PubMed ID: 17179896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid-attenuated inversion recovery hypointensity of the pulvinar nucleus of patients with Alzheimer disease: its possible association with iron accumulation as evidenced by the t2(*) map.
    Moon WJ; Kim HJ; Roh HG; Choi JW; Han SH
    Korean J Radiol; 2012; 13(6):674-83. PubMed ID: 23118565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.
    Liem MK; Lesnik Oberstein SA; Versluis MJ; Maat-Schieman ML; Haan J; Webb AG; Ferrari MD; van Buchem MA; van der Grond J
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1180-5. PubMed ID: 22923513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ characterization and mapping of iron compounds in Alzheimer's disease tissue.
    Collingwood JF; Mikhaylova A; Davidson M; Batich C; Streit WJ; Terry J; Dobson J
    J Alzheimers Dis; 2005 Aug; 7(4):267-72. PubMed ID: 16131727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.
    Whitwell JL; Kantarci K; Weigand SD; Lundt ES; Gunter JL; Duffy JR; Strand EA; Machulda MM; Spychalla AJ; Drubach DA; Petersen RC; Lowe VJ; Jack CR; Josephs KA
    J Alzheimers Dis; 2015; 45(4):1109-17. PubMed ID: 25649655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI for iron mapping in Alzheimer's disease.
    Langkammer C; Ropele S; Pirpamer L; Fazekas F; Schmidt R
    Neurodegener Dis; 2014; 13(2-3):189-91. PubMed ID: 23942230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor density changes in Alzheimer amygdala and putamen.
    Barg J; Belcheva M; Rowinski J; Ho A; Burke WJ; Chung HD; Schmidt CA; Coscia CJ
    Brain Res; 1993 Dec; 632(1-2):209-15. PubMed ID: 8149229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
    Xian-hui D; Wei-juan G; Tie-mei S; Hong-lin X; Jiang-tao B; Jing-yi Z; Xi-qing C
    J Trace Elem Med Biol; 2015 Apr; 30():118-23. PubMed ID: 25575693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias.
    Varma AR; Laitt R; Lloyd JJ; Carson KJ; Snowden JS; Neary D; Jackson A
    Acta Neurol Scand; 2002 May; 105(5):355-64. PubMed ID: 11982486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.